Clinical Trials Browser

Completed × Carcinoma, Squamous Cell × Erlotinib Hydrochloride × Clear all

NCT00942734 2025-05-01

Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma

Phase 2 Completed

49 enrolled 5 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00966472 2020-04-21

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT00563784 2019-11-20

TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

68 enrolled 11 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Adenocarcinoma, Clear Cell, Carcinoma, Giant Cell

NCT00369512 2017-05-30

RAD0503

Phase 2 Completed

15 enrolled 9 charts

Carcinoma, Squamous Cell, Neoplasms

NCT00476476 2015-05-07

Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar

Phase 2 Completed

41 enrolled 7 charts

Carcinoma, Squamous Cell

NCT00113347 2012-02-27

Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 1 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms